scispace - formally typeset
Open AccessJournal ArticleDOI

Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning.

Daniel J. Drucker
- 02 Mar 2021 - 
- Vol. 33, Iss: 3, pp 479-498
TLDR
The increased prevalence of obesity, diabetes, and cardiovascular risk factors in people hospitalized with severe COVID-19 illness has engendered considerable interest in the metabolic aspects of SARS-CoV-2-induced pathophysiology as mentioned in this paper.
About
This article is published in Cell Metabolism.The article was published on 2021-03-02 and is currently open access. It has received 145 citations till now. The article focuses on the topics: Diabetes mellitus.

read more

Citations
More filters
Journal ArticleDOI

Vaccination, symptomatic infection and negative conversion of viral RNA by body mass index, diabetes, and age: An observational study

TL;DR: In this article , the associations of vaccine received with symptomatic infection with SARS-CoV-2 and negative conversion rate of viral RNA by BMI, diabetes, and age are unclear.
Journal ArticleDOI

Bidirectionality between Cardiometabolic Diseases and COVID-19: Role of Humoral Immunity

TL;DR: In this paper , a review summarizes current evidence of the bidirectional influences between cardiometabolic diseases (diabetes, adiposity, hypertension, CVDs) and SARS-CoV-2 antibodies induced from infection and vaccination based on human studies.
Journal ArticleDOI

COVID-19 ed endocrinologia: il caso della tiroide, del diabete e dell’ipovitaminosi D

TL;DR: In questa rassegna si discuteranno i risultati dei principali studi ad oggi pubblicati che hanno analizzato le alterazioni della funzione tiroidea, dei livelli di vitamina D and il compenso glicometabolico nei pazienti ospedalizzati per polmonite da SARS-CoV-2 and il loro impatto sull'outcome clinico as mentioned in this paper.
Journal ArticleDOI

Association between RAAS Antagonism and COVID-19-related Mortality in Patients with Overweight/Obesity-related Hypertension: A Retrospective Cohort Study.

TL;DR: In this paper , the authors evaluated the association between ARB/ACEI use and COVID-19 severity in patients with overweight/obesity-related hypertension and found that exposure to ARB and ACEI before hospitalization was significantly associated with lower mortality (odds ratio [OR] = 0.362, 95% confidence interval [CI] 0.450 to 1.067, p =0.093).
References
More filters
Journal ArticleDOI

Dexamethasone in Hospitalized Patients with Covid-19

TL;DR: In patients hospitalized with Covid-19, the use of dexamethasone resulted in lower 28-day mortality among those who were receiving either invasive mechanical ventilation or oxygen alone at randomization but not among those receiving no respiratory support.
Related Papers (5)